Important Investment Disclaimer

Investments in securities are subject to market risks. Please read all relevant documents carefully and consult your financial advisor before investing.

TejiFactor Logo
Invest in what's next

TejiFactor helps you discover high-potential stock themes and SEBI-approved insights to grow your wealth with confidence.

Quick Links

  • Compare
  • Simulator
  • News

Company

  • About Us
  • Terms & Conditions
  • Privacy Policy
  • Legal Disclaimer

Support

  • Help Center
  • FAQ
  • Security
Google Play
App Store

TejiFactor Private Limited Corporate Identification Number (CIN) : U62090GJ2025PTC169520

Corporate Address: 524, 5th Floor, Binori B Square 3, Sindhubhavan Rd, Bodakdev, Ahmedabad, Gujarat – 380059

© 2026 TejiFactor Pvt Ltd.

Pharma & CDMO Theme

Pharma & CDMO Theme

Managed by RAJ PITHWA
Publish on 01 Jun, 2026

Investing in leading pharmaceutical and CDMO companies driving global healthcare innovation and manufacturing.

About the Theme

The Pharma & CDMO Theme focuses on leading pharmaceutical manufacturers and contract development & manufacturing organizations benefiting from rising global healthcare demand, increasing outsourcing by innovators, strong export opportunities, and India's growing position as a trusted global pharmaceutical manufacturing hub.

Rebalance FrequencyOn Need Basis
Last Rebalance27 Jun, 2026
Next Rebalance-
Info
1M Return10.8001
Volatility
Low

Minimum Investment Amount

₹29094.40

Get access for ₹1999.00/mo
See all plans & benefits
0 Investors
16 Subscriber
Share on

About the Manager

RAJ PITHWA
RAJ PITHWA
Manages 9 themes

Raj Pithwa is a passionate and analytical Research Analyst specializing in Equity Markets and investment research. He possesses strong expertise in analyzing listed companies, market trends, sector performance, and financial statements to identify potential investment opportunities. With a research-driven approach, Raj focuses on fundamental analysis, valuation methodologies, market sentiment assessment, and macroeconomic developments influencing equity markets. He is skilled in studying business models, earnings performance, industry dynamics, and risk factors to provide insightful and data-backed market perspectives.

Pharma & CDMO ThemeAuto / Auto Ancillary Theme+7 more